Block:admin/longevity-research
@admin / longevity-researchmission
Longevity Research
SucceededElapsed
773.2s
Cost
Free
Tokens
0
0 in · 0 out
Events
28
click to inspect
live output
Starting mission longevity-research…
==> Longevity-research mission tick starting
==> Swarm tick starting. KB: {'entities': 131, 'relations': 0}
==> Goal: Anchor the first human-validated causal relation in the mTORC1–autophagy–inflammaging axis by re-gating to the IL-6/hs-C
── Phase 1: Director
1. Colocalized two-sample Mendelian Randomization of *RPTOR* and *TSC2* cis-pQTL instruments (F-statistic > 10) against circulating IL-6 and hs-CRP GWAS summary statistics, requiring col
── Phase 2: Scouts
Focus: FOCUS AREAS:
[clinicaltrials] fetched 0 items
[opentargets] error: HTTP Error 400: Bad Request
[opentargets] fetched 0 items
[europepmc] fetched 60 items
[medrxiv] fetched 30 items
[biorxiv] fetched 30 items
[pubmed] fetched 0 items
[pubmed] esearch error: <urlopen error [Errno -3] Temporary failure in name resolution>
Items: 120
── Phase 3: Synthesizer
── Phase 4: Critic
── Phase 5: Curator
Findings: 0, Hypotheses: 4
── Phase 6: Reporter
── Phase 7: Director-meta
==> Tick complete. Findings: 0, Hypotheses: 4
==> Tick complete.
Outputs
{
"result": " This tick, the swarm narrowed its scope to a single, high-stakes objective: forging the first causal edge in the mTORC1–autophagy–inflammaging axis by linking genetic variation in the core mTORC1 regulators *RPTOR* and *TSC2* to the inflammatory markers IL-6 and high-sensitivity CRP (hs-CRP). Rather than casting a wide net, we deliberately suspended work on broader cytokine panels, in vivo longevity models, and trans-pQTL instruments to prioritize three integrative workstreams: (1) designing a stringent colocalized two-sample Mendelian Randomization (MR) framework using cis-pQTL instruments with F-statistics above 10 and SuSiE/coloc posterior probabilities exceeding 0.8 to rule out linkage disequilibrium confounding; (2) mapping the mechanistic coupling between mTORC1-dependent TFEB/TFE3 nuclear shuttling, autophagy flux, and NF-κB activation in human macrophages; and (3) de-risking these genetic instruments by cross-referencing them against myeloid-specific QTL atlases and scanning for metabolic pleiotropy.\n\nNo new causal relations were added to the knowledge graph this tick. The database now contains 131 entities but zero verified edges, and while four hypotheses were refined and five recent review articles were ingested to provide contextual scaffolding, no primary genetic or experimental findings were produced. In this sense, the most consequential “discovery” is methodological: the swarm has established the exact evidentiary threshold required to draw its first arrow. Only cis-pQTL instruments that survive strict colocalization with IL-6 or hs-CRP loci *and* demonstrate myeloid-lineage relevance will be accepted, and macrophage autophagy flux must be quantitatively tied to NF-κB-driven IL-6 secretion before any causal claim can be registered.\n\nThe biological mechanism under interrogation can be understood as a cellular recycling shutdown. mTORC1 acts as a nutrient sensor that, when chronically overactive, phosphorylates the transcription factors TFEB and TFE3—master regulators of autophagy—trapping them in the cytoplasm. Their exclusion from the nucleus stalls the cell’s waste-clearance programs, and the resulting accumulation of damaged proteins and organelles is hypothesized to amplify NF-κB signaling, particularly in macrophages. Those stressed macrophages would then secrete IL-6, which in turn drives hepatic CRP production. If validated, this chain would provide a concrete molecular bridge between nutrient-sensing genetics and low-grade chronic inflammation, or “inflammaging.”\n\nAt present, evidence for this specific causal chain remains entirely theoretical. This tick generated no human MR effect estimates, no macrophage experimental data, and no animal model results. The planned MR analysis would leverage human GWAS and pQTL summary statistics, offering potentially strong causal inference *if* the instruments survive colocalization and pleiotropy testing. The macrophage workstream would operate at the in vitro level using primary or iPSC-derived cells. In vivo longevity or cancer models remain deprioritized until this first edge is anchored, leaving the knowledge graph at zero relations.\n\nThe outstanding questions are whether *RPTOR* and *TSC2* cis-pQTLs of sufficient strength actually exist that colocalize with IL-6 or hs-CRP loci at the required statistical threshold; whether myeloid eQTL atlases confirm immune-cell-specific action rather than confounding metabolic effects; and whether autophagy suppression can be quantitatively linked to NF-κB RelA/p65 activation and cytokine output in human macrophages. If the genetic architecture cooperates, the swarm will next execute the colocalized MR, mine macrophage datasets for phospho-TFEB and LC3 flux readouts, and interrogate metabolic pleiotropy. Overall confidence in the direction remains provisional: the hypothesis is biologically plausible and analytically tractable, but it is still a hypothesis awaiting its first empirical anchor.\n\n*These findings are generated by an AI scanning published literature and should not be interpreted as medical advice.*",
"items_processed": 120,
"findings": 0,
"hypotheses": 4
}Inference calls7